- Home
- PDSB vs BODI Comparison
PDSB vs BODI Comparison
Compare PDSB & BODI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDSB
- BODI
- Stock Information
- Founded
- PDSB 2005
- BODI 1998
- Country
- PDSB United States
- BODI United States
- Employees
- PDSB N/A
- BODI N/A
- Industry
- PDSB Biotechnology: Pharmaceutical Preparations
- BODI Industrial Machinery/Components
- Sector
- PDSB Health Care
- BODI Industrials
- Exchange
- PDSB Nasdaq
- BODI Nasdaq
- Market Cap
- PDSB 58.7M
- BODI 49.0M
- IPO Year
- PDSB N/A
- BODI N/A
- Fundamental
- Price
- PDSB $0.96
- BODI $5.51
- Analyst Decision
- PDSB Strong Buy
- BODI Strong Buy
- Analyst Count
- PDSB 3
- BODI 3
- Target Price
- PDSB $10.00
- BODI $10.67
- AVG Volume (30 Days)
- PDSB 795.8K
- BODI 13.5K
- Earning Date
- PDSB 05-14-2025
- BODI 05-05-2025
- Dividend Yield
- PDSB N/A
- BODI N/A
- EPS Growth
- PDSB N/A
- BODI N/A
- EPS
- PDSB N/A
- BODI N/A
- Revenue
- PDSB N/A
- BODI $418,796,000.00
- Revenue This Year
- PDSB N/A
- BODI N/A
- Revenue Next Year
- PDSB N/A
- BODI $1.13
- P/E Ratio
- PDSB N/A
- BODI N/A
- Revenue Growth
- PDSB N/A
- BODI N/A
- 52 Week Low
- PDSB $1.05
- BODI $5.14
- 52 Week High
- PDSB $4.42
- BODI $10.80
- Technical
- Relative Strength Index (RSI)
- PDSB 32.49
- BODI 36.73
- Support Level
- PDSB $1.19
- BODI $6.61
- Resistance Level
- PDSB $1.41
- BODI $7.55
- Average True Range (ATR)
- PDSB 0.10
- BODI 0.65
- MACD
- PDSB -0.03
- BODI -0.18
- Stochastic Oscillator
- PDSB 2.11
- BODI 0.00
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.
About BODI The Beachbody Company Inc. Class A Common Stock
The Beachbody Co Inc is a health and wellness platform providing fitness, nutrition and stress-reducing programs to its customers. The product offerings of the company include Digital Subscriptions, Nutritional Products, and Connected Fitness Products. It earns the majority of its revenue from the United States. The company operates and manages its business in two operating segments, Beachbody and Other.